2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | - | - | - | 2.836 | 66.321 | 47.830 | 7.780 | 8.273 | 8.248 |
Total Income - EUR | - | - | - | - | 7.010 | 66.321 | 47.845 | 7.780 | 8.274 | 8.248 |
Total Expenses - EUR | - | - | - | - | 4.157 | 17.668 | 14.100 | 597 | 600 | 8.196 |
Gross Profit/Loss - EUR | - | - | - | - | 2.853 | 48.653 | 33.744 | 7.183 | 7.674 | 52 |
Net Profit/Loss - EUR | - | - | - | - | 2.666 | 47.989 | 33.311 | 6.954 | 7.487 | -30 |
Employees | - | - | - | - | 0 | 2 | 2 | 0 | 0 | 1 |
Check the financial reports for the company - Liovixrar S.r.l.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Check Financial Rating2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 5.965 | 6.275 | 6.547 | 7.092 | 7.835 | 8.505 | - | - | - | - |
Current Assets | - | - | - | - | 5.863 | 55.097 | 39.082 | 12.734 | 16.317 | 6.980 |
Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Receivables | - | - | - | - | 38 | 5.317 | 1 | 2 | 9 | 8 |
Cash | - | - | - | - | 5.826 | 49.781 | 39.081 | 12.732 | 16.308 | 6.972 |
Shareholders Funds | - | - | - | - | 13.659 | 58.770 | 45.683 | 19.231 | 20.897 | 12.247 |
Social Capital | - | - | - | - | 952 | 934 | 916 | 896 | 898 | 896 |
Debts | - | - | - | - | 709 | 4.163 | 491 | 50 | 1.695 | 697 |
Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "6820 - 6820" | |||||||||
CAEN Financial Year | 6820 |
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Reports that can be accessed based on the subscription:
Get the contact details for any company and get in touch with it.